Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO
15.10.19 | CTech
This site uses cookies to ensure the best viewing experience for our readers.
89Bio
2 stories about 89Bio
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture
28.10.18 | Lilach Baumer
Tag does not exist. Please try again.